TSPAN9 Antibody, HRP conjugated
-
中文名稱：TSPAN9兔多克隆抗體, HRP偶聯
-
貨號：CSB-PA025167LB01HU
-
規格：￥880
-
其他：
產品詳情
-
產品名稱：Rabbit anti-Homo sapiens (Human) TSPAN9 Polyclonal antibody
-
Uniprot No.：
-
基因名：TSPAN9
-
別名：TSPAN9; NET5; Tetraspanin-9; Tspan-9; Tetraspan NET-5
-
宿主：Rabbit
-
反應種屬：Human
-
免疫原：Recombinant Human Tetraspanin-9 protein (107-203AA)
-
免疫原種屬：Homo sapiens (Human)
-
標記方式：HRP
-
克隆類型：Polyclonal
-
抗體亞型：IgG
-
純化方式：>95%, Protein G purified
-
濃度：It differs from different batches. Please contact us to confirm it.
-
保存緩沖液：Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4 -
產品提供形式：Liquid
-
應用范圍：ELISA
-
Protocols：
-
儲存條件：Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
貨期：Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
-
用途：For Research Use Only. Not for use in diagnostic or therapeutic procedures.
產品評價
相關產品
靶點詳情
-
基因功能參考文獻：
- The proliferation, migration and invasion of human gastric cancer SGC7901 cells were significantly inhibited by overexpression of Tspan9. PMID: 27177197
- TSPAN9 is an endosomal tetraspanin whose depletion has a pronounced effect on the entry of several viruses that fuse in the early endosome. PMID: 26865714
- Findings suggest a role for Tspan9 in regulating platelet function in concert with other platelet tetraspanins and their associated proteins. PMID: 18795891
- tetraspanin CD9 has a role in determining vascular smooth muscle cell injury phenotypes PMID: 18799160
-
亞細胞定位：Membrane; Multi-pass membrane protein.
-
蛋白家族：Tetraspanin (TM4SF) family
-
組織特異性：Expressed in megakaryocytes and platelets (at protein level).
-
數據庫鏈接：
Most popular with customers
-
YWHAB Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC, IF, FC
Species Reactivity: Human, Mouse, Rat
-
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC
Species Reactivity: Human
-
-
-
-
-
-
